Short-Term Adjuvant Atorvastatin Improves Frequency Domain Indices of Heart Rate Variability in Stable Systolic Heart Failure

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cardiovascular Drugs and Therapy

• Publication date

  2005-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10557-005-2219-8PMID 16142595
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Statin use and survival outcomes in elderly patients with heart failure.

  2005cited by this paper
• Statin therapy is associated with lower mortality among patients with severe heart failure.

  2004cited by this paper
• Short-Term Statin Therapy Improves Cardiac Function and Symptoms in Patients With Idiopathic Dilated Cardiomyopathy

  2003cited by this paper
• Simvastatin Normalizes Autonomic Neural Control in Experimental Heart Failure

  2003influential reference
• The renal dopaminergic system, neurohumoral activation, and sodium handling in heart failure.

  2002cited by this paper
• Fluvastatin, a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor, Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction

  2002cited by this paper
• Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure.

  2002cited by this paper
• Neurohormonal activation, the renal dopaminergic system and sodium handling in patients with severe heart failure under vasodilator therapy

  2001cited by this paper
• Improvement of Left Ventricular Remodeling and Function by Hydroxymethylglutaryl Coenzyme A Reductase Inhibition With Cerivastatin in Rats With Heart Failure After Myocardial Infarction

  2001cited by this paper
• Heart rate variability after long-term treatment with atorvastatin in hypercholesterolaemic patients with or without coronary artery disease.

  2001cited by this paper
• Role of Nitric Oxide in Central Sympathetic Outflow

  2001cited by this paper
• Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects.

  2000cited by this paper
• Heart rate variability patterns before ventricular tachycardia onset in patients with an implantable cardioverter defibrillator. Participating Investigators of ICD-HRV Italian Study Group.

  2000cited by this paper
• Low Heart Rate Variability in a 2-Minute Rhythm Strip Predicts Risk of Coronary Heart Disease and Mortality From Several Causes: The ARIC Study

  2000cited by this paper
• Heart rate variability patterns before ventricular tachycardia onset in patients with an implantable cardioverter defibrillator

  2000cited by this paper
• Simvastatin upregulates coronary vascular endothelial nitric oxide production in conscious dogs.

  2000cited by this paper
• Neurohumoral activations in congestive heart failure: correlations with cardiac function, heart rate variability, and baroreceptor sensitivity.

  1999cited by this paper
• Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men.

  1999cited by this paper
• Regulation of sympathetic nerve activity in heart failure: a role for nitric oxide and angiotensin II.

  1999cited by this paper
• Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart).

  1998cited by this paper
• Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

  1998cited by this paper
• The sympathetic nervous system in chronic heart failure.

  1998cited by this paper
• Heart rate variability in idiopathic dilated cardiomyopathy: characteristics and prognostic value.

  1997cited by this paper
• Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

  1997cited by this paper
• Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy.

  1997cited by this paper
• Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. The Zutphen Study.

  1997cited by this paper
• Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

  1996cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

  1996cited by this paper
• Heart rate variability. Standards of measurement, physiological interpretation, and clinical use

  1996cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Heart rate variability in left ventricular dysfunction and heart failure: effects and implications of drug treatment.

  1994cited by this paper
• The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure.

  1992cited by this paper
• Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure.

  1991cited by this paper
• Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis.

  1988cited by this paper

• Evaluation of Autonomic Nervous System Through Spectral Analysis in Patients with Ischemic Heart Failure: A Systematic Review

  2024cites this paper
• Optimal effectiveness of heart failure management — an umbrella review of meta-analyses examining the effectiveness of interventions to reduce (re)hospitalizations in heart failure

  2022cites this paper
• Effect of HMG-Co-A Reductase Inhibitors on Cardiac Autonomic Neuropathy in Diabetic Patients

  2021cites this paper
• No benefits of statins for sudden cardiac death prevention in patients with heart failure and reduced ejection fraction: A meta-analysis of randomized controlled trials

  2017cites this paper
• Are statins beneficial for chronic heart failure? First update.

  2017cites this paper
• Lipids, Statins and Heart Failure: An Update.

  2016cites this paper
• Lipophilic Statin Versus Rosuvastatin (Hydrophilic) Treatment for Heart Failure: a Meta-Analysis and Adjusted Indirect Comparison of Randomised Trials

  2016influential citation
• Genetic, Epigenetic, and Environmental Factors Influencing Neurovisceral Integration of Cardiovascular Modulation: Focus on Multiple Sclerosis

  2015cites this paper
• Are statins beneficial for chronic heart failure?

  2015cites this paper
• Atorvastatin improves cardiac function and remodeling in chronic non-ischemic heart failure: A clinical and pre-clinical study

  2015cites this paper
• The Role of Statins in Heart Failure

  2015cites this paper
• Effects of lipophilic statins for heart failure: a meta-analysis of 13 randomised controlled trials.

  2014cites this paper
• Statins and the autonomic nervous system.

  2014cites this paper
• Simvastatin but not ezetimibe reduces sympathetic activity despite similar reductions in cholesterol levels.

  2014cites this paper
• Statins in heart failure: do we need another trial?

  2013cites this paper
• Statin Therapy in Heart Failure: For Good, for Bad, or Indifferent?

  2013cites this paper
• Efeito das estatinas na variabilidade da frequência cardíaca durante a fase aguda do infarto agudo do miocárdio com supradesnivelamento do segmento st

  2012cites this paper
• Statins in non‐ischaemic cardiomyopathy: an update on our current clinical and pathophysiological understanding

  2011cites this paper
• Pharmacologic modulation of parasympathetic activity in heart failure

  2011cites this paper
• Sympathoinhibitory effects of statins in chronic kidney disease: are they clinically relevant?

  2011cites this paper
• Efficacy of statin therapy in chronic systolic cardiac insufficiency: a meta-analysis.

  2011cites this paper
• Effect of atorvastatin in patients with chronic heart failure – insights from randomized clinical trials

  2010cites this paper
• Simvastatin reduces sympathetic activity in men with hypertension and hypercholesterolemia

  2010cites this paper
• Contemporary Reviews in Cardiovascular Medicine

  2010cites this paper
• [Baroreflex sensitivity in patients with chronic heart failure: the clinical significance and impact of therapy].

  2010cites this paper
• Statins decrease dendritic arborization in rat sympathetic neurons by blocking RhoA activation

  2009influential citation
• [Atorvastatin dreduces sympathetic activity and improves baroreceptor reflex sensitivity in patients with hypercholesterolemia and hypertension].

  2009cites this paper
• Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure.

  2009cites this paper
• Effects of Lipid-Altering Therapies on Ventricular Arrhythmias and Sudden Cardiac Death

  2009influential citation
• Atorvastatin reduces sympathetic activity and increases baroreceptor reflex sensitivity in patients with hypercholesterolaemia and systemic arterial hypertension.

  2009cites this paper
• Potential autonomic nervous system effects of statins in heart failure.

  2008cites this paper
• A panel study of air pollution in subjects with heart failure: negative results in treated patients

  2008cites this paper
• Statins in heart failure - a failure?

  2008cites this paper
• Should a statin be prescribed to every patient with heart failure?

  2008cites this paper
• Antiarrhythmic effects of statins in heart failure.

  2008cites this paper
• Heart rate recovery and prognosis in heart failure patients

  2008cites this paper
• ДИНАМИКА ПОКАЗАТЕЛЕЙ ВАРИАБЕЛЬНОСТИ РИТМА СЕРДЦА У ПАЦИЕНТОВ С ПАРОКСИЗМАЛЬНОЙ ФОРМОЙ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ ПРИ ЛЕЧЕНИИ АТОРВАСТАТИНОМ

  2008cites this paper
• Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy.

  2008cites this paper
• Clinical investigations of statins in heart failure: ventricular function and anti-remodeling.

  2008cites this paper
• Atorvastatin and statins in the treatment of heart failure

  2007cites this paper
• Derliane Glonvezynski dos Santos Beck

  2007cites this paper
• Autonomic Nervous System Activity and Decline as Prognostic Indicators of Cardiovascular and Cerebrovascular Events: The ‘PROOF’ Study

  2007cites this paper
• Drug Insight: statins for nonischemic heart failure—evidence and potential mechanisms

  2007cites this paper
• Potential role of statin therapy in heart failure, atrial fibrillation and aortic stenosis.

  2006cites this paper
• Statins and Autonomic Function in Chronic Heart Failure

  2005cites this paper